By Sandip Pravin Patel, MD, and Martin Edelman, MD Posted: August 21, 2020 Dr. Sandip Pravin Patel Dr. Martin Edelman […] Read more
Posted: August 21, 2020 In addition to her role as a senior research fellow in Trinity College Dublin, Anne-Marie Baird, BSc, PhD, has been elected as the new president of […] Read more
By Mary Jo Fidler, MD Posted: August 21, 2020 At the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program Plenary Session, an early look at data from the […] Read more
By Kara Nyberg, PhD Posted: August 21, 2020 A multitude of factors contribute to disparities in lung cancer care, including sex, race, education level, income, geographic region, and access to […] Read more
By Leah K. LawrencePosted: August 21, 2020 In July 2019, England’s government announced its goal to make the country “smoke free” by 2030.1 That may be easier said than done, […] Read more
By Lawson Eng, MD, FRCPC, and William K. Evans, MD, FRCPC Posted: August 21, 2020 IN REFERENCE TO: Cao P, Jeon J, Levy DT, et al. Potential impact of cessation […] Read more
By Jennifer Byrne Posted: August 21, 2020 For nearly 2 decades, Bonnie Anderson has defied incredible odds in the face of mesothelioma, hairy cell leukemia, breast cancer, lung cancer, and […] Read more
By Ross Soo, MB, BS, PhD, FRACP Posted: August 21, 2020 Dr. Ross Soo Impressive progress has been achieved in many aspects of lung cancer. Over the past […] Read more
By Luis E. Raez, MD, FACP, FCCP Posted: August 21, 2020 Our current electronic medical records (EMR) are equipped with telehealth capability. Some of us have spent the last 2 […] Read more
By Erik MacLaren, PhD Posted: August 21, 2020 The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Merck’s immune checkpoint inhibitor pembrolizumab, adding a new tissue-agnostic indication […] Read more